BIOABIOANASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+33.8%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+33.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$95.64M+22.3%
2024$78.19M+61.6%
2023$48.40M+21.1%
2022$39.97M-